Federal Court Halts Implementation of 340B Dispute Resolution Rule
A U.S. District Court recently halted the implementation of a dispute resolution rule for the 340B Drug Pricing Program.
Reimbursement
-
Read more: Federal Court Halts Implementation of 340B Dispute Resolution Rule -
Read more: Ensuring 340B Discounts Trickle Down to Low-Income Patients Ensuring 340B Discounts Trickle Down to Low-Income Patients
Congress must take action to ensure these discounts benefit low-income 340B eligible patients, as intended.
-
Read more: HHS’s 340B Advisory Opinion: Helpful or Harmful? HHS’s 340B Advisory Opinion: Helpful or Harmful?
A recent advisory opinion released by HHS left many 340B advocates hungry for answers and pharmaceutical manufacturers frustrated.
-
Read more: In Defense of Medicare Coverage of Innovative Technologies In Defense of Medicare Coverage of Innovative Technologies
The Medicare Coverage of Innovative Technologies rule will encourage innovation and promote patient access.
-
Read more: Issuing the Most Favored Nation Interim Final Rule Was a Mistake Issuing the Most Favored Nation Interim Final Rule Was a Mistake
Procedurally, the Trump administration’s issuance of the Most Favored Nation Interim Final Rule was a mistake.
-
Read more: Cuts to 340B Drug Reimbursement May be Harmful During COVID-19 Cuts to 340B Drug Reimbursement May be Harmful During COVID-19
Slashing Medicare reimbursement for safety-net hospitals may have devastating effects on the individuals who rely on these hospitals.
-
Read more: Can We Expect Legislation on Surprise Medical Billing? I’d Be Surprised Can We Expect Legislation on Surprise Medical Billing? I’d Be Surprised
To shake legislation on surprise medical billing loose, the President would need to take a side and expend political capital on a creative solution.
-
Read more: Telehealth Policy Brought to the Fore in the COVID-19 Pandemic Telehealth Policy Brought to the Fore in the COVID-19 Pandemic
The COVID-19 pandemic has highlighted the value of telehealth as both a tool of necessity as well as of innovation.
-
Read more: Patient Advocacy Groups – Pharma in Disguise? Patient Advocacy Groups – Pharma in Disguise?
By Phebe Hong The mission of the Patient Access Network Foundation (PANF) is “[t]o help underinsured people with life-threatening, chronic and rare diseases get the medications and treatments they need by assisting with their out-of-pocket costs and advocating for improved access and affordability.” PANF proudly boasts that since 2004, it has “provided nearly 1 million…
-
Read more: Ending Surprise Emergency Bills Ending Surprise Emergency Bills
Let’s hope that Congress will act this session to protect patients and fix this broken market.
